Treating Stroke-Like Episodes with Carbamazepine May Trigger Psychosis
DOI:
https://doi.org/10.47310/iarjmsr.2021.V02i01.02Keywords:
COVID-19, neurological, SARS-CoV-2, brain, nerves.Abstract
The indication for applying CBZ was obviously the SLE. It was propagated to treat all SLEs with anti-seizure drugs (ASDs) irrespective if the patient presents with seizures or shows epileptiform discharges on electroencephalography (EEG). This management of SLEs has been recently challenged. SLEs may not only be driven by seizures, as mentioned in the introduction, as they occur in the absence of clinical or subclinical seizures and in the absence of epileptiform discharges on EEG.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.